Plasma Derived Medicine Market By Product Type (Immunoglobulins (Ig), Coagulation Factors, Albumin, C1 Esterase Inhibitors, Fibrinogen Concentrates, Other), By Application (Immunology, Haematology, Critical Care, Pulmonology, Neurology, Infectious Diseases, Other), By Delivery Mode (Intravenous, Subcutaneous, Topical), By End-User (Hospitals, Clinics, Blood & Plasma Donation Centers, Diagnostic Laboratories, Academic and Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Immunoglobulins (Ig)
• Coagulation Factors
• Albumin
• C1 Esterase Inhibitors
• Fibrinogen Concentrates
• Other

By Application

• Immunology
• Haematology
• Critical Care
• Pulmonology
• Neurology
• Infectious Diseases
• Other

 By Delivery Mode

• Intravenous
• Subcutaneous
• Topical

By End User

• Hospitals
• Clinics
• Blood & Plasma Donation Centers
• Diagnostic Laboratories
• Academic and Research Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• CSL Behring
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Octapharma
• Kedrion Biopharma
• Baxter International Inc.
• Biotest AG
• ADMA Biologics
• Bio Products Laboratory Ltd
• Kamada Pharmaceuticals
• SK Plasma
• Taibang Biological Group Co., Ltd.
• Arthrex, Inc.
• Johnson & Johnson
• Shanghai RAAS Blood Products Co., Ltd.
• China Biologic Products Holdings, Inc.
• LFB Group
• Antaris Pharma